RCUS NYSE
Arcus Biosciences, Inc.
1W: -4.3%
1M: -10.3%
3M: +25.7%
YTD: +2.5%
1Y: +169.1%
3Y: +30.5%
5Y: -16.3%
$23.43
-0.44 (-1.84%)
Weekly Expected Move ±9.0%
$19
$22
$24
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$236M
Revenue
+67.4% YoY
$-369M
Net Income
+5.6% YoY
$-489M
Free Cash Flow
-61.4% YoY
88.2%
Gross Margin
-788.2%
Op. Margin
-752.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-66.1%
ROA-32.2%
ROIC125.3%
Valuation
P/E-8.0
P/B5.6
EV/EBITDA-5.4
Leverage
Debt/Equity0.16
Current Ratio4.36
Interest Cov.-15.8x
Quality Scores
Piotroski F2/9
Altman Z1.39
Beneish M-3.29